A fast automated screening method for the detection of blood transfusion in sports

Drug Testing and Analysis

Volumn 6, Issue 11-12, 2014, Pages 1141-1143

  Leuenberger, Nicolas ^a,b   Ansermet, Camille ^a,b   Pottgiesser, Torben ^c   Baume, Norbert ^a,b   Robinson, Neil ^a,b   Saugy, Martial ^a,b   Schumacher, Yorck Olaf ^d  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

Author keywords

Anti doping; Blood transfusion; Iron

Indexed keywords

BIOMARKERS; BLOOD; COST EFFECTIVENESS; SPORTS;

ANTI-DOPING; AUTOMATED SCREENING; BLOOD TRANSFUSION; COST EFFECTIVE; MEASUREMENTS OF; SCREENING METHODS; SIMPLE++;

IRON;

EDETIC ACID; IRON; BIOLOGICAL MARKER; CHELATING AGENT;

ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; HUMAN; IRON BLOOD LEVEL; LABORATORY AUTOMATION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPORT; AUTOMATION; BLOOD; DOPING; LIMIT OF DETECTION; REPRODUCIBILITY;

AUTOMATION; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHELATING AGENTS; DOPING IN SPORTS; EDETIC ACID; HUMANS; IRON; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS;

EID: 84923144965     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1676     Document Type: Article

References (10)

1. N. Monfort, R. Ventura, A. Latorre, V. Belalcazar, M. Lopez, J. Segura Urinary di-(2-ethylhexyl)phthalate metabolites in athletes as screening measure for illicit blood doping: A comparison study with patients receiving blood transfusion. Transfusion 2010, 50, 145.
2. Y.O. Schumacher, M. Saugy, T. Pottgiesser, N. Robinson Detection of EPO doping and blood doping: The haematological module of the athlete biological passport. Drug Test. Anal. 2012, 4, 846.
3. D.B. Kim-Shapiro, J. Lee, M.T. Gladwin Storage lesion: Role of red blood cell breakdown. Transfusion 2011, 51, 844.
4. E.A. Hod, G.M. Brittenham, G.B. Billote, R.O. Francis, Y.Z. Ginzburg, J.E. Hendrickson, J. Jhang, J. Schwartz, S. Sharma, S. Sheth, A.N. Sireci, H.L. Stephens, B.A. Stotler, B.S. Wojczyk, J.C. Zimring, S.L. Spitalnik Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011, 118, 6675.
5. N. Leuenberger, Y.O. Schumacher, S. Pradervand, T. Sander, M. Saugy, T. Pottgiesser Circulating microRNAs as biomarkers for detection of autologous blood transfusion. PLoS One 2013, 8, e66309.
6. F.E. Smith, J. Herbert, J. Gaudin, D.J. Hennessy, G.R. Reid Serum iron determination using ferene triazine. Clin. Biochem. 1984, 17, 306.
7. B. Berglund Development of techniques for the detection of blood doping in sport. Sports Med. 1988, 5, 127.
8. M.V.L. Rao, L.V.L. Sastry, M. Srinivasan, V. Subrahmanyan Inhibition of oxidation of ascorbic acid by EDTA. J. Sci. Food Agric. 1959, 10, 436.
9. S. Eskelinen, M. Haikonen, S. Raisanen Ferene-S as the chromogen for serum iron determinations. Scand. J. Clin. Lab. Invest. 1983, 43, 453.
10. A. Jaspers, F. Baron, E. Willems, L. Seidel, E.T. Wiegerinck, D.W. Swinkels, Y. Beguin Serum hepcidin following autologous hematopoietic cell transplantation: An illustration of the interplay of iron status, erythropoiesis and inflammation. Haematologica 2014, 99, e35-e37.